Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	ANO4 GABRG1 TPCN2 TMEM63C PKD2L1 PKD2 ANO3	1.43e-04	193	117	7	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	ANO4 GABRG1 TPCN2 TMEM63C PKD2L1 PKD2 ANO3	1.62e-04	197	117	7	GO:0022834
GeneOntologyMolecularFunction	GTPase activating protein binding	GAPVD1 GNAI1 GNAI3	1.77e-04	19	117	3	GO:0032794
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor binding	GNAI1 GNAI3	3.37e-04	5	117	2	GO:0031821
GeneOntologyMolecularFunction	G-protein beta/gamma-subunit complex binding	GNAI1 GNAI2 GNAI3	4.10e-04	25	117	3	GO:0031683
Domain	Gprotein_alpha_I	GNAI1 GNAI2 GNAI3	1.21e-05	8	114	3	IPR001408
Domain	GproteinA_insert	GNAI1 GNAI2 GNAI3	1.17e-04	16	114	3	IPR011025
Domain	-	GNAI1 GNAI2 GNAI3	1.17e-04	16	114	3	1.10.400.10
Domain	G-alpha	GNAI1 GNAI2 GNAI3	1.17e-04	16	114	3	PF00503
Domain	G_alpha	GNAI1 GNAI2 GNAI3	1.17e-04	16	114	3	SM00275
Domain	Gprotein_alpha_su	GNAI1 GNAI2 GNAI3	1.41e-04	17	114	3	IPR001019
Domain	PKD_2	PKD2L1 PKD2	3.65e-04	5	114	2	IPR003915
Pathway	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	ADCY9 GNAI1 GNAI2 GNAI3	1.23e-06	14	86	4	MM14669
Pathway	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	ADCY9 GNAI1 GNAI2 GNAI3	1.23e-06	14	86	4	M750
Pathway	KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY	ADCY9 GNAI1 GNAI2 GNAI3	2.89e-06	17	86	4	M47544
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY	GNAI1 GNAI2 GNAI3	1.20e-05	8	86	3	M47642
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY	GNAI1 GNAI2 GNAI3	1.20e-05	8	86	3	M47643
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY	ADCY9 GNAI1 GNAI2 GNAI3	1.74e-05	26	86	4	M47553
Pathway	KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY	GNAI1 GNAI2 GNAI3	1.79e-05	9	86	3	M47641
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	ADCY9 GNAI1 GNAI2 GNAI3	2.04e-05	27	86	4	M47519
Pathway	KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY	GNAI1 GNAI2 GNAI3	3.49e-05	11	86	3	M47797
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	GNAI1 GNAI2 GNAI3	4.63e-05	12	86	3	M47558
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	GNAI1 GNAI2 GNAI3	4.63e-05	12	86	3	M47559
Pathway	PID_S1P_S1P4_PATHWAY	GNAI1 GNAI2 GNAI3	7.60e-05	14	86	3	M64
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	ADCY9 GNAI1 GNAI2 GNAI3	9.02e-05	39	86	4	MM14496
Pathway	PID_THROMBIN_PAR1_PATHWAY	AKAP13 GNAI1 GNAI2 GNAI3	1.33e-04	43	86	4	M238
Pathway	REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	ADCY9 GNAI1 GNAI2 GNAI3	1.33e-04	43	86	4	M29837
Pathway	REACTOME_GABA_B_RECEPTOR_ACTIVATION	ADCY9 GNAI1 GNAI2 GNAI3	1.33e-04	43	86	4	M954
Pathway	REACTOME_GABA_B_RECEPTOR_ACTIVATION	ADCY9 GNAI1 GNAI2 GNAI3	1.46e-04	44	86	4	MM15709
Pathway	REACTOME_GPER1_SIGNALING	ADCY9 GNAI1 GNAI2 GNAI3	1.59e-04	45	86	4	M45008
Pathway	REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	ADCY9 GNAI1 GNAI2 GNAI3	2.05e-04	48	86	4	M10775
Pathway	WP_G_PROTEIN_SIGNALING_PATHWAYS	ADCY9 AKAP13 GNAI1 GNAI2 GNAI3	2.20e-04	90	86	5	MM15882
Pathway	WP_G_PROTEIN_SIGNALING	ADCY9 AKAP13 GNAI1 GNAI2 GNAI3	2.31e-04	91	86	5	M39426
Pathway	PID_S1P_S1P1_PATHWAY	GNAI1 GNAI2 GNAI3	2.69e-04	21	86	3	M103
Pathway	PID_S1P_META_PATHWAY	GNAI1 GNAI2 GNAI3	2.69e-04	21	86	3	M155
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12	GNAI1 GNAI2 GNAI3	3.10e-04	22	86	3	MM15016
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12	GNAI1 GNAI2 GNAI3	3.10e-04	22	86	3	M841
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	ADCY9 GNAI1 GNAI2 GNAI3	3.24e-04	54	86	4	M26911
Pathway	WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR	GNAI1 GNAI2 GNAI3	3.55e-04	23	86	3	MM15952
Pathway	PID_S1P_S1P2_PATHWAY	GNAI1 GNAI2 GNAI3	4.04e-04	24	86	3	M268
Pathway	WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION	GNAI1 GNAI2 GNAI3	4.58e-04	25	86	3	M39384
Pathway	REACTOME_GABA_RECEPTOR_ACTIVATION	ADCY9 GNAI1 GNAI2 GNAI3	4.85e-04	60	86	4	MM15708
Pathway	REACTOME_GABA_RECEPTOR_ACTIVATION	ADCY9 GNAI1 GNAI2 GNAI3	4.85e-04	60	86	4	M976
Pathway	WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES	GAPVD1 HEATR5A FCHO1 ZFYVE9 AP2A2 MRC2 RABGAP1L HADHB SORL1	5.14e-04	381	86	9	M48063
Pathway	PID_ENDOTHELIN_PATHWAY	ADCY9 GNAI1 GNAI2 GNAI3	5.85e-04	63	86	4	M8
Pathway	REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION	CACNA1C GNAI1 GNAI2	6.43e-04	28	86	3	M10679
Pathway	PID_LYSOPHOSPHOLIPID_PATHWAY	ADCY9 GNAI1 GNAI2 GNAI3	6.58e-04	65	86	4	M15
Pathway	PID_S1P_S1P3_PATHWAY	GNAI1 GNAI2 GNAI3	7.14e-04	29	86	3	M55
Pathway	PID_AR_NONGENOMIC_PATHWAY	GNAI1 GNAI2 GNAI3	8.71e-04	31	86	3	M213
Pathway	REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS	ANO4 CANX PARP6 ANO3	8.71e-04	70	86	4	M46438
Pathway	REACTOME_OPIOID_SIGNALLING	ADCY9 GNAI1 GNAI2 GNAI3	9.19e-04	71	86	4	MM14491
Pathway	REACTOME_SIGNAL_AMPLIFICATION	GNAI1 GNAI2 GNAI3	1.05e-03	33	86	3	MM15020
Pathway	WP_PURINERGIC_SIGNALING	GNAI1 GNAI2 GNAI3	1.05e-03	33	86	3	M39855
Pathway	REACTOME_SIGNAL_AMPLIFICATION	GNAI1 GNAI2 GNAI3	1.05e-03	33	86	3	M9379
Pathway	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	PLXNA4 PLXNA2	1.29e-03	9	86	2	MM15030
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	ADCY9 GNAI1 GNAI2 ADAM17 GNAI3	1.35e-03	134	86	5	M29840
Pathway	WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY	GNAI1 GNAI2 GNAI3	1.47e-03	37	86	3	M42558
Pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	ADCY9 GNAI1 GNAI2 GNAI3	1.80e-03	85	86	4	M3578
Pathway	WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY	PKD2 GNAI1 GNAI2 GNAI3	1.80e-03	85	86	4	M48315
Pathway	PID_ER_NONGENOMIC_PATHWAY	GNAI1 GNAI2 GNAI3	1.84e-03	40	86	3	M41
Pathway	REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION	ADCY9 AP2A2 GNAI1 GNAI2 GNAI3	1.86e-03	144	86	5	MM14501
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	CACNA1C ADCY9 GNAI1 GNAI2 GNAI3	2.04e-03	147	86	5	MM15854
Pathway	REACTOME_OPIOID_SIGNALLING	ADCY9 GNAI1 GNAI2 GNAI3	2.21e-03	90	86	4	M6467
Pathway	KEGG_GAP_JUNCTION	ADCY9 GNAI1 GNAI2 GNAI3	2.21e-03	90	86	4	M4013
Pathway	PID_CXCR3_PATHWAY	GNAI1 GNAI2 GNAI3	2.27e-03	43	86	3	M222
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	CACNA1C ADCY9 GNAI1 GNAI2 GNAI3	2.29e-03	151	86	5	M39329
Pathway	REACTOME_INDUCTION_OF_CELL_CELL_FUSION	ANO4 ANO3	2.75e-03	13	86	2	M46426
Pubmed	Isoforms of mammalian adenylyl cyclase: multiplicities of signaling.	ADCY10 ADCY9 GNAI1 GNAI2 GNAI3	8.42e-10	14	119	5	14993377
Pubmed	Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in splenocytes by Galphai proteins.	GNAI1 GNAI2 GNAI3	3.91e-08	3	119	3	16962188
Pubmed	Lipopolysaccharide- and gram-positive bacteria-induced cellular inflammatory responses: role of heterotrimeric Galpha(i) proteins.	GNAI1 GNAI2 GNAI3	3.91e-08	3	119	3	15788486
Pubmed	Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in macrophages by Galpha(i) proteins.	GNAI1 GNAI2 GNAI3	3.91e-08	3	119	3	17484771
Pubmed	Differential effects of inhibitory G protein isoforms on G protein-gated inwardly rectifying K+ currents in adult murine atria.	GNAI1 GNAI2 GNAI3	3.91e-08	3	119	3	29342363
Pubmed	GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.	GNAI1 GNAI2 GNAI3	3.91e-08	3	119	3	30836096
Pubmed	Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle.	ADCY9 GNAI1 GNAI2 GNAI3	6.31e-08	12	119	4	9611134
Pubmed	Most central nervous system D2 dopamine receptors are coupled to their effectors by Go.	GNAI1 GNAI2 GNAI3	1.56e-07	4	119	3	11248120
Pubmed	Localization of Gi alpha proteins in the centrosomes and at the midbody: implication for their role in cell division.	GNAI1 GNAI2 GNAI3	1.56e-07	4	119	3	17635935
Pubmed	Mouse gene knockout and knockin strategies in application to alpha subunits of Gi/Go family of G proteins.	GNAI1 GNAI2 GNAI3	1.56e-07	4	119	3	11771389
Pubmed	CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains.	GNAI1 GNAI2 GNAI3	1.56e-07	4	119	3	11168387
Pubmed	High-throughput microarray detection of olfactory receptor gene expression in the mouse.	OR2M7 OR2M2 OR2M5	1.56e-07	4	119	3	15377787
Pubmed	The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics.	GNAI1 GNAI2 GNAI3	1.56e-07	4	119	3	18832081
Pubmed	Specific interaction of Gαi3 with the Oa1 G-protein coupled receptor controls the size and density of melanosomes in retinal pigment epithelium.	GNAI1 GNAI2 GNAI3	1.56e-07	4	119	3	21931697
Pubmed	Coupling of Airway Smooth Muscle Bitter Taste Receptors to Intracellular Signaling and Relaxation Is via Gαi1,2,3.	GNAI1 GNAI2 GNAI3	1.56e-07	4	119	3	28145731
Pubmed	Oxidized human neuroglobin acts as a heterotrimeric Galpha protein guanine nucleotide dissociation inhibitor.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	12860983
Pubmed	Coupling of dopamine receptor subtypes to multiple and diverse G proteins.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	10978845
Pubmed	An essential role for Gα(i2) in Smoothened-stimulated epithelial cell proliferation in the mammary gland.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	26373672
Pubmed	G-protein alpha subunit interaction and guanine nucleotide dissociation inhibitor activity of the dual GoLoco motif protein PCP-2 (Purkinje cell protein-2).	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	16298104
Pubmed	Defective macrophage migration in Gαi2- but not Gαi3-deficient mice.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	22706085
Pubmed	Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	2820999
Pubmed	Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-αi and caveolin I.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	22230296
Pubmed	RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with guanine nucleotide dissociation inhibitor Activity.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	11387333
Pubmed	HIV-1 triggers WAVE2 phosphorylation in primary CD4 T cells and macrophages, mediating Arp2/3-dependent nuclear migration.	GNAI1 GNAI2 GNAI3	3.89e-07	5	119	3	24415754
Pubmed	Requirement of Gαi1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	25078664
Pubmed	Identification of the platelet ADP receptor targeted by antithrombotic drugs.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	11196645
Pubmed	Gialpha and Gbeta subunits both define selectivity of G protein activation by alpha2-adrenergic receptors.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	16371464
Pubmed	Development of the mammalian axial skeleton requires signaling through the Gα(i) subfamily of heterotrimeric G proteins.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	23236180
Pubmed	Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	19401591
Pubmed	Intrinsic planar polarity mechanisms influence the position-dependent regulation of synapse properties in inner hair cells.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	30975754
Pubmed	Cloning and characterization of a novel regulator of G protein signalling in human platelets.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	11955952
Pubmed	Molecular evolution of the actin family.	ACTRT3 ACTRT2 ACTRT1	7.75e-07	6	119	3	12077353
Pubmed	Characterization of RGS5 in regulation of G protein-coupled receptor signaling.	GNAI1 GNAI2 GNAI3	7.75e-07	6	119	3	11253162
Pubmed	CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteins.	GNAI1 GNAI2 GNAI3	1.35e-06	7	119	3	15251452
Pubmed	Activation state-dependent interaction between Galphai and p67phox.	GNAI1 GNAI2 GNAI3	1.35e-06	7	119	3	16782902
Pubmed	GAIP is membrane-anchored by palmitoylation and interacts with the activated (GTP-bound) form of G alpha i subunits.	GNAI1 GNAI2 GNAI3	1.35e-06	7	119	3	8986788
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	GABRG1 EFCAB5 CACNA1C SPTBN2 CAMSAP3 KRBA2 C9orf43 DST AP2A2 PLXNA4 GNAI1 GNAI2 GNAI3 HADHB ABCC2 CADPS2 PLXNA2 LCMT1	2.05e-06	1442	119	18	35575683
Pubmed	Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor.	GNAI1 GNAI2 GNAI3	2.16e-06	8	119	3	12509430
Pubmed	Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis.	GNAI1 GNAI2 GNAI3	3.23e-06	9	119	3	38651641
Pubmed	Purification and identification of G protein-coupled receptor protein complexes under native conditions.	CANX GNAI1 GNAI2 GNAI3	3.82e-06	31	119	4	17215244
Pubmed	The LGN protein promotes planar proliferative divisions in the neocortex but apicobasal asymmetric terminal divisions in the retina.	GNAI1 GNAI2 GNAI3	4.61e-06	10	119	3	26755700
Pubmed	The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families.	GNAI1 GNAI2 GNAI3	4.61e-06	10	119	3	8552586
Pubmed	The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2.	GNAI1 GNAI2 GNAI3	4.61e-06	10	119	3	8521505
Pubmed	Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse.	GNAI1 GNAI2 GNAI3	8.40e-06	12	119	3	2508088
Pubmed	RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao.	GNAI1 GNAI2 GNAI3	8.40e-06	12	119	3	10926822
Pubmed	Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein.	GNAI1 GNAI2 GNAI3	1.09e-05	13	119	3	8208289
Pubmed	Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins.	GNAI1 GNAI2 GNAI3	1.09e-05	13	119	3	16892066
Pubmed	A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells.	GNAI1 GNAI2 GNAI3	1.09e-05	13	119	3	24135232
Pubmed	Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice.	GNAI2 GNAI3	1.16e-05	2	119	2	25944935
Pubmed	Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.	GNAI2 GNAI3	1.16e-05	2	119	2	17289675
Pubmed	Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils.	GNAI2 GNAI3	1.16e-05	2	119	2	26976957
Pubmed	mGluR2 acts through inhibitory Galpha subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses.	GRM2 GNAI2	1.16e-05	2	119	2	16606834
Pubmed	Enhanced expression of TACE contributes to elevated levels of sVCAM-1 in endometriosis.	ADAM17 VCAM1	1.16e-05	2	119	2	30395261
Pubmed	Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes.	GNAI2 GNAI3	1.16e-05	2	119	2	11073886
Pubmed	Gαi2- and Gαi3-deficient mice display opposite severity of myocardial ischemia reperfusion injury.	GNAI2 GNAI3	1.16e-05	2	119	2	24858945
Pubmed	Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels.	PKD2L1 PKD2	1.16e-05	2	119	2	29899465
Pubmed	Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease.	GNAI2 GNAI3	1.16e-05	2	119	2	18521956
Pubmed	The human genome encodes at least three non-allellic G proteins with alpha i-type subunits.	GNAI1 GNAI3	1.16e-05	2	119	2	2440724
Pubmed	FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus.	GNAI2 GNAI3	1.16e-05	2	119	2	21788441
Pubmed	A small multigene family encodes Gi signal-transduction proteins.	GNAI2 GNAI3	1.16e-05	2	119	2	3120178
Pubmed	Novel actin-related proteins Arp-T1 and Arp-T2 as components of the cytoskeletal calyx of the mammalian sperm head.	ACTRT2 ACTRT1	1.16e-05	2	119	2	12243744
Pubmed	Targeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivity.	GNAI2 GNAI3	1.16e-05	2	119	2	11158953
Pubmed	Gαi2 is the essential Gαi protein in immune complex-induced lung disease.	GNAI2 GNAI3	1.16e-05	2	119	2	23225882
Pubmed	Identification of the structural motif responsible for trimeric assembly of the C-terminal regulatory domains of polycystin channels PKD2L1 and PKD2.	PKD2L1 PKD2	1.16e-05	2	119	2	20408813
Pubmed	Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17).	ADAM17 VCAM1	1.16e-05	2	119	2	12878595
Pubmed	Identification of two cDNAs for human actin-related proteins (Arps) that have remarkable similarity to conventional actin.	ACTRT3 ACTRT2	1.16e-05	2	119	2	11750065
Pubmed	Canonical and noncanonical g-protein signaling helps coordinate actin dynamics to promote macrophage phagocytosis of zymosan.	GNAI2 GNAI3	1.16e-05	2	119	2	25225330
Pubmed	Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells.	GNAI1 GNAI2	1.16e-05	2	119	2	22308501
Pubmed	An obligatory requirement for the heterotrimeric G protein Gi3 in the antiautophagic action of insulin in the liver.	GNAI2 GNAI3	1.16e-05	2	119	2	17296938
Pubmed	Requirement of Gαi1 and Gαi3 in interleukin-4-induced signaling, macrophage M2 polarization and allergic asthma response.	GNAI1 GNAI3	1.16e-05	2	119	2	33754034
Pubmed	Reconstitution of transport-active multidrug resistance protein 2 (MRP2; ABCC2) in proteoliposomes.	CANX ABCC2	1.16e-05	2	119	2	12222674
Pubmed	Galphai2-mediated signaling events in the endothelium are involved in controlling leukocyte extravasation.	GNAI2 GNAI3	1.16e-05	2	119	2	17360531
Pubmed	Gαi2- and Gαi3-specific regulation of voltage-dependent L-type calcium channels in cardiomyocytes.	GNAI2 GNAI3	1.16e-05	2	119	2	21966394
Pubmed	G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.	GNAI1 GNAI2 GNAI3	1.72e-05	15	119	3	24478091
Pubmed	Cloning and characterization of the human phosphoinositide-specific phospholipase C-beta 1 (PLC beta 1).	GNAI1 GNAI2 GNAI3	1.72e-05	15	119	3	11118617
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	TNC TENM4 ERAP2 LNPEP ADAM17 SORL1	2.24e-05	164	119	6	32409323
Pubmed	Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.	GNAI1 GNAI2 GNAI3	2.56e-05	17	119	3	18453587
Pubmed	Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.	EFCAB5 OPCML PKD2	3.07e-05	18	119	3	25288136
Pubmed	Structural Basis for Plexin Activation and Regulation.	PLXNA4 PLXNA2	3.47e-05	3	119	2	27397516
Pubmed	Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers.	PLXNA4 PLXNA2	3.47e-05	3	119	2	17296555
Pubmed	The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway.	GNAI1 GNAI3	3.47e-05	3	119	2	8626678
Pubmed	GAP1(IP4BP)/RASA3 mediates Galphai-induced inhibition of mitogen-activated protein kinase.	GNAI2 GNAI3	3.47e-05	3	119	2	18952607
Pubmed	The loss of Gnai2 and Gnai3 in B cells eliminates B lymphocyte compartments and leads to a hyper-IgM like syndrome.	GNAI2 GNAI3	3.47e-05	3	119	2	23977324
Pubmed	G(o) controls the hyperpolarization-activated current in embryonic stem cell-derived cardiocytes.	GNAI2 GNAI3	3.47e-05	3	119	2	18156202
Pubmed	Stabilization of C5a receptor--G-protein interactions through ligand binding.	GNAI2 GNAI3	3.47e-05	3	119	2	7962171
Pubmed	Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.	GNAI1 GNAI2	3.47e-05	3	119	2	23467353
Pubmed	71.67 T lymphocyte activation is accompanied by the down-regulation of three G alpha genes.	GNAI2 GNAI3	3.47e-05	3	119	2	7656338
Pubmed	Agonists activate Gi1 alpha or Gi2 alpha fused to the human mu opioid receptor differently.	GNAI1 GNAI2	3.47e-05	3	119	2	12068084
Pubmed	Regulation of the human leukocyte-derived arginine aminopeptidase/endoplasmic reticulum-aminopeptidase 2 gene by interferon-gamma.	ERAP2 LNPEP	3.47e-05	3	119	2	15691326
Pubmed	Inhibitory and stimulatory G proteins of adenylate cyclase: cDNA and amino acid sequences of the alpha chains.	GNAI1 GNAI2	3.47e-05	3	119	2	3092218
Pubmed	Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells.	PLXNA4 PLXNA2	3.47e-05	3	119	2	18625214
Pubmed	Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.	TNC VCAM1	3.47e-05	3	119	2	22300502
Pubmed	Polycystin-2 interacts with troponin I, an angiogenesis inhibitor.	PKD2L1 PKD2	3.47e-05	3	119	2	12525172
Pubmed	Preferential Coupling of Dopamine D2S and D2L Receptor Isoforms with Gi1 and Gi2 Proteins-In Silico Study.	GNAI1 GNAI2	3.47e-05	3	119	2	31936673
Pubmed	RXFP1 Receptor Activation by Relaxin-2 Induces Vascular Relaxation in Mice via a Gαi2-Protein/PI3Kß/γ/Nitric Oxide-Coupled Pathway.	GNAI2 GNAI3	3.47e-05	3	119	2	30233409
Pubmed	The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus.	GNAI2 GNAI3	3.47e-05	3	119	2	8663053
Pubmed	Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.	PLXNA4 PLXNA2	3.47e-05	3	119	2	22777942
Pubmed	Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content.	ATP8B1 ABCC2	3.47e-05	3	119	2	19228692
Pubmed	Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides.	ERAP2 LNPEP	3.47e-05	3	119	2	21314638
Pubmed	Genome-wide approaches reveal functional interleukin-4-inducible STAT6 binding to the vascular cell adhesion molecule 1 promoter.	STAT6 VCAM1	3.47e-05	3	119	2	21464207
Interaction	RGS18 interactions	GNAI1 GNAI2 GNAI3	1.41e-05	9	113	3	int:RGS18
Interaction	GPSM2 interactions	GNAI1 GNAI2 LSM11 GNAI3	2.62e-05	31	113	4	int:GPSM2
Interaction	NCF2 interactions	CAMSAP3 GNAI1 GNAI2 GNAI3	2.99e-05	32	113	4	int:NCF2
Interaction	RGS5 interactions	GNAI1 GNAI2 GNAI3	3.64e-05	12	113	3	int:RGS5
Cytoband	1q24	ADCY10 RABGAP1L BRINP2	1.87e-05	20	119	3	1q24
Cytoband	5q15	ERAP2 LNPEP RIOK2	1.56e-04	40	119	3	5q15
Cytoband	Ensembl 112 genes in cytogenetic band chr5q15	ERAP2 LNPEP RIOK2	4.97e-04	59	119	3	chr5q15
Cytoband	Ensembl 112 genes in cytogenetic band chr15q23	NOX5 MYO9A PARP6	7.53e-04	68	119	3	chr15q23
Cytoband	1p13	CD101 GNAI3	8.83e-04	17	119	2	1p13
Cytoband	Ensembl 112 genes in cytogenetic band chr4q22	COX7A2P2 SMARCAD1 PKD2	9.63e-04	74	119	3	chr4q22
Cytoband	1p22.3	DNASE2B SSX2IP	1.49e-03	22	119	2	1p22.3
GeneFamily	Plexins	PLXNA4 PLXNA2	6.00e-04	9	75	2	683
GeneFamily	Anoctamins	ANO4 ANO3	7.48e-04	10	75	2	865
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY10 ADCY9	7.48e-04	10	75	2	53
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTBN2 PLEKHS1 AKAP13 PLEKHM3 CADPS2	1.65e-03	206	75	5	682
GeneFamily	Aminopeptidases\|CD molecules	ERAP2 LNPEP	2.22e-03	17	75	2	104
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ANO4 COL4A5 TNC ST8SIA1 TENM4 DST DISP1	6.36e-07	185	118	7	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA1C COL4A5 TNC CAPN6 ST8SIA1 TENM4 SSX2IP	6.60e-07	186	118	7	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANO4 COL4A5 TNC ST8SIA1 TENM4 DST DISP1	6.84e-07	187	118	7	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY10 GABRG1 CACNA1C ABCA13 PKD2L1 ABCC2	4.69e-06	162	118	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs\|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUP210L CANX OPCML LNPEP TMF1 AKAP13	7.30e-06	175	118	6	53e96956019f984decc1c81376ebc88fbf3c4d40
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	ACTRT3 CANX DST ALG10 ADAM17 UTY	7.54e-06	176	118	6	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANO4 CACNA1C TNC TENM4 MRC2 PLXNA4	9.13e-06	182	118	6	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TNC TTC39C RFX2 DST PKD2 AKAP13	9.72e-06	184	118	6	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL4A5 TNC CAPN6 ST8SIA1 TENM4 SSX2IP	1.00e-05	185	118	6	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA1C TNC ST8SIA1 TENM4 DST PLXNA2	1.00e-05	185	118	6	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANO4 CACNA1C TNC TENM4 PLXNA4 DISP1	1.07e-05	187	118	6	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.13e-05	189	118	6	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.13e-05	189	118	6	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C COL4A5 TNC TENM4 PLXNA4	1.13e-05	189	118	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.17e-05	190	118	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.17e-05	190	118	6	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.20e-05	191	118	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C COL4A5 TNC TENM4 PLXNA4	1.20e-05	191	118	6	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.24e-05	192	118	6	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANO4 CACNA1C TENM4 PLXNA4 ANO3 DISP1	1.24e-05	192	118	6	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.24e-05	192	118	6	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.24e-05	192	118	6	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.24e-05	192	118	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.24e-05	192	118	6	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4 VCAM1	1.31e-05	194	118	6	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C MYO9A TNC DST SSX2IP PLXNA2	1.39e-05	196	118	6	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 CACNA1C TENM4 DST PKD2 ANO3	1.43e-05	197	118	6	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A5 ABCA13 TNC TMEM63C PLEKHS1 TENM4	1.47e-05	198	118	6	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ALG10 PKD2 AKAP13 UTY PLXNA2 VCAM1	1.52e-05	199	118	6	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte\|3m / Sample Type, Dataset, Time_group, and Cell type.	COL4A5 TNC AQP4 MRC2 HADHB VCAM1	1.56e-05	200	118	6	98d7f577b31a603bf835bf9b4ea31999445cf0e5
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANO4 COL4A5 TNC DST PKD2 PLXNA4	1.56e-05	200	118	6	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANO4 COL4A5 TNC DST PKD2 PLXNA4	1.56e-05	200	118	6	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial\|3m / Sample Type, Dataset, Time_group, and Cell type.	COL4A5 TNC CANX MRC2 HADHB VCAM1	1.56e-05	200	118	6	38b51f337e183011e3ff32997ec26d8a424c6b78
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRSS56 CCDC168 FSIP2 ABCC2	2.53e-05	64	118	4	bf923a66b17e717b8d3817b9d0e201b82a7e4a88
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRSS56 CCDC168 FSIP2 ABCC2	2.53e-05	64	118	4	a3e852600c53b11175eb579e92962fa711f5678b
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRSS56 CCDC168 FSIP2 ABCC2	2.53e-05	64	118	4	f8f43ad9354c786b418bac54614f96f50e8bea68
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EFCAB5 COL4A5 SPTBN2 ATP8B1 CADPS2	4.24e-05	145	118	5	bfa196ac1db7acbfcbb2ba9f137036a95e16e091
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY10 GABRG1 ABCA13 PKD2L1 ABCC2	4.24e-05	145	118	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPCN2 MYO9A TENM4 ADAM17 VCAM1	7.38e-05	163	118	5	8dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPCN2 MYO9A TENM4 ADAM17 VCAM1	7.38e-05	163	118	5	fd243ca223079033be480a24817a399f281fa4d4
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO4 CACNA1C COL4A5 PLXNA4 ANO3	7.60e-05	164	118	5	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	facs-Lung-Endomucin-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM PGD CD101 BRINP2 SORL1	8.05e-05	166	118	5	5126d8f02314717eed341d867856fd4fe16c5118
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C TNC PKD2 PLXNA4 ANO3	8.05e-05	166	118	5	94636dbc039f794c735960c3425e00bdd5523602
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM PGD CD101 BRINP2 SORL1	8.05e-05	166	118	5	3037bdca38c3a65eacfa644219cc43c54e303749
ToppCell	facs-Heart-LV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG1 NUP210L TENM4 MRC2 PKD2	8.75e-05	169	118	5	849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1C ADCY9 DST BRINP2	8.84e-05	88	118	4	5582fd7bac60c690ecd1f2aff1d446ccb69f79b9
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG1 NUP210L TENM4 MRC2 PKD2	1.06e-04	176	118	5	fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG1 NUP210L TENM4 MRC2 PKD2	1.06e-04	176	118	5	f25251abd4ef9fb077a978f9f9f658af58e4e0d2
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RTL5 CAMSAP3 TMEM63C KRBA2 CADPS2	1.09e-04	177	118	5	a235ff4f37a7622216526191efc4832fb8ed6957
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	ACTRT3 CANX DST ALG10 UTY	1.09e-04	177	118	5	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PKD2L1 ST8SIA1 TENM4 CADPS2 ANO3	1.15e-04	179	118	5	d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TNC ST8SIA1 TENM4 CADPS2 ANO3	1.15e-04	179	118	5	b35a7f8115c997c390201da01d7cb10b10769aec
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANO4 CACNA1C TENM4 MRC2 PLXNA4	1.21e-04	181	118	5	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 TNC MRC2 GNAI1	1.37e-04	186	118	5	3dae539cce15fcf2b1b32e981d7febe94c03c600
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL4A5 TNC CAPN6 ST8SIA1 TENM4	1.41e-04	187	118	5	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A5 SPTBN2 ATP8B1 MBOAT2 CADPS2	1.41e-04	187	118	5	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C COL4A5 TNC PLXNA4	1.44e-04	188	118	5	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A5 SPTBN2 ATP8B1 MBOAT2 CADPS2	1.48e-04	189	118	5	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	ANO4 CACNA1C TNC TENM4 PLXNA4	1.48e-04	189	118	5	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A5 SPTBN2 ATP8B1 MBOAT2 CADPS2	1.48e-04	189	118	5	c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A5 MYO9A GNAI1 CADPS2 UTY	1.48e-04	189	118	5	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM CFLAR AKAP13 UTY PLXNA2	1.48e-04	189	118	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 ADCY9 PLXNA4	1.48e-04	189	118	5	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 TNC MRC2 VCAM1	1.48e-04	189	118	5	bd91bdfe35294e60d980259b70fe9e60dca2743f
ToppCell	PBMC-Severe-Myeloid-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MGAM ABCA13 PGD MBOAT2 SORL1	1.52e-04	190	118	5	cb62ece5929896dfba30a4f563c6ba5a5712b71e
ToppCell	PBMC-Severe-Myeloid-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MGAM ABCA13 PGD MBOAT2 SORL1	1.52e-04	190	118	5	fedd266198d294d8da8c9e217e5e0cb8b2e1b566
ToppCell	COVID-19_Severe-Myeloid_G\|COVID-19_Severe / Disease group, lineage and cell class	MGAM ABCA13 PGD MBOAT2 SORL1	1.52e-04	190	118	5	8a81cb90273c361e9fdfaa0a31806da253fa1388
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	CACNA1C FBXO40 DST AKAP13 HADHB	1.52e-04	190	118	5	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	CACNA1C DST RABGAP1L AKAP13 HADHB	1.55e-04	191	118	5	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CACNA1C TNC TENM4 PLXNA4	1.55e-04	191	118	5	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	GAPVD1 CANX LNPEP ALG10 UTY	1.55e-04	191	118	5	9454f642c3621370fa23640b631301346b300950
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 PLXNA4 VCAM1	1.59e-04	192	118	5	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TNC TEAD4 RFX2 AKAP13 PLXNA2	1.59e-04	192	118	5	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 PLXNA4 VCAM1	1.59e-04	192	118	5	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4	1.59e-04	192	118	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	NS-critical-d_0-4-Lymphoid-NK\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SLC2A8 TNC USP38 MRC2 GNAI1	1.63e-04	193	118	5	1b29525c5936d1b779253b8c20f059fa091c6127
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ANO4 POLE2 OPCML RFWD3 PLXNA4	1.63e-04	193	118	5	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4	1.63e-04	193	118	5	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	ATP8B1 OPCML CADPS2 PLXNA2 VCAM1	1.63e-04	193	118	5	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22\|World / Primary Cells by Cluster	TENM4 PLXNA4 AKAP13 PLXNA2 SORL1	1.63e-04	193	118	5	3b927d4b8ecb21a408424ef91a23746c21741f49
ToppCell	LAM-LAM-LAM+\|LAM / Condition, Lineage and Cell class	ANO4 CACNA1C FBXO40 CAPN6 ANO3	1.67e-04	194	118	5	4ba73a9145ed44896e359f6df9c1f32bbe24a189
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4	1.67e-04	194	118	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	facs-Skin-Telogen-3m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST LNPEP GNAI3 HADHB PLXNA2	1.67e-04	194	118	5	ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC ST8SIA1 MRC2 PLXNA4	1.67e-04	194	118	5	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LAM-LAM\|LAM / Condition, Lineage and Cell class	ANO4 CACNA1C FBXO40 CAPN6 ANO3	1.67e-04	194	118	5	4c6561a64711c72c4ef4a3e67c41d2e8d31fba57
ToppCell	facs-Skin-Telogen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST LNPEP GNAI3 HADHB PLXNA2	1.67e-04	194	118	5	bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MGAM ABCA13 PGD CFLAR SORL1	1.71e-04	195	118	5	fb3dc2c8fd125f23d0c3aa211520778aac8d6dda
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC39C SSX2IP PLXNA4 CADPS2 SORL1	1.71e-04	195	118	5	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNC AQP4 DST LSM11 VCAM1	1.75e-04	196	118	5	19993604ee64ba85e3f53a784fcf1c934e862f61
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TNC CAPN6 OPCML TENM4 VCAM1	1.75e-04	196	118	5	028a06ed92f1c058dcbeacd335625bf529e87a7b
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C TNC TENM4 DST MRC2	1.79e-04	197	118	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon\|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type.	TNC AQP4 DST MRC2 HADHB	1.79e-04	197	118	5	58b957efd006f43c2fe55071d5c6d06c2e367e72
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A5 MYO9A CAMSAP3 AQP4 CADPS2	1.79e-04	197	118	5	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1C DST GNAI1 CADPS2 VCAM1	1.79e-04	197	118	5	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1C DST GNAI1 CADPS2 VCAM1	1.79e-04	197	118	5	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-oRG\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	COL4A5 TNC AQP4 MRC2 HADHB	1.84e-04	198	118	5	72dc49aa107d0cc6206eb67b577c73e190855125
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	TNC AQP4 MRC2 HADHB VCAM1	1.84e-04	198	118	5	3811d9e3e54bbe8b208c591697e43b55ab5bbf0e
ToppCell	moderate-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PGD MBOAT2 AKAP13 GNAI1 SORL1	1.84e-04	198	118	5	7ecce5e266bb08797088cc8f8309e0c7b48df5c9
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 TNC KIF20B RFWD3 RAET1L	1.84e-04	198	118	5	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MGAM ABCA13 PGD GNAI2 SORL1	1.88e-04	199	118	5	5919933c4b842b98fc98685dc8c72c8dd32c6ea3
Disease	Cholestasis of pregnancy	ATP8B1 ABCC2 VCAM1	3.35e-06	8	117	3	C0268318
Disease	McCune Albright syndrome (implicated_via_orthology)	GNAI1 GNAI2 GNAI3	3.35e-06	8	117	3	DOID:1858 (implicated_via_orthology)
Disease	bitter alcoholic beverage consumption measurement	MGAM FBXO40 ERCC4 STAT6 PLXNA2 SORL1	1.55e-05	133	117	6	EFO_0010092
Disease	endoplasmic reticulum aminopeptidase 2 measurement	ERAP2 LNPEP	1.56e-05	2	117	2	EFO_0801566
Disease	polycystic kidney disease 2 (implicated_via_orthology)	PKD2L1 PKD2	4.66e-05	3	117	2	DOID:0110859 (implicated_via_orthology)
Disease	smoking behavior	GAPVD1 ERCC4 TMEM63C OPCML PLXNA4 CADPS2 PLXNA2 SORL1	6.70e-05	341	117	8	EFO_0004318
Disease	Familial intrahepatic cholestasis of pregnancy	ATP8B1 VCAM1	9.30e-05	4	117	2	C3489728
Disease	smoking status measurement	CACNA1C CNBD1 GAPVD1 ERCC4 COX7A2P2 TMEM63C ST8SIA1 OPCML TENM4 LNPEP PLXNA4 CADPS2 PLXNA2 SORL1	2.06e-04	1160	117	14	EFO_0006527
Disease	endoplasmic reticulum aminopeptidase 1 measurement	ERAP2 LNPEP	3.23e-04	7	117	2	EFO_0008119
Disease	severe pre-eclampsia (is_marker_for)	ERAP2 LNPEP	4.30e-04	8	117	2	DOID:13129 (is_marker_for)
Disease	Mental deterioration	CACNA1C SORL1	5.51e-04	9	117	2	C0234985
Disease	Mild cognitive disorder	CACNA1C SORL1	5.51e-04	9	117	2	C1270972
Disease	Anemia, Sickle Cell	CACNA1C VCAM1	6.87e-04	10	117	2	C0002895
Disease	decadienedioic acid (C10:2-DC) measurement	PKD2L1 SLC17A1	6.87e-04	10	117	2	EFO_0800598
Disease	pregnenediol disulfate (C21H34O8S2) measurement	SLC17A1 ABCC2	8.38e-04	11	117	2	EFO_0800279
Disease	risk-taking behaviour	GABRG1 CACNA1C GAPVD1 ERCC4 TMEM63C TENM4 GNAI2 CADPS2 PLXNA2 SORL1	9.46e-04	764	117	10	EFO_0008579
Disease	Cholestasis	ABCC2 CADPS2 VCAM1 SORL1	9.81e-04	110	117	4	C0008370
Disease	pipecolate measurement	PLEKHM3 PLXNA2	1.18e-03	13	117	2	EFO_0021006
Disease	3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement	TENM4 SLC17A1	1.18e-03	13	117	2	EFO_0021053
Disease	sleep quality	CACNA1C ERCC4 TENM4 GNAI1	1.27e-03	118	117	4	EFO_0005272
Disease	alcohol consumption measurement	GABRG1 CACNA1C MGAM ERCC4 COX7A2P2 MBOAT2 OPCML STAT6 RABGAP1L PLXNA4 GNAI2 PLXNA2 SORL1	1.31e-03	1242	117	13	EFO_0007878
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	ANO4 GAPVD1 ERCC4 COX7A2P2 TENM4 ERAP2 PLXNA4 CADPS2 PLXNA2 SORL1	1.35e-03	801	117	10	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD2L1 PKD2	1.38e-03	14	117	2	DOID:898 (implicated_via_orthology)
Disease	X-21470 measurement	SLC17A1 ABCC2	1.38e-03	14	117	2	EFO_0800817
Disease	lysophosphatidylcholine 16:1 measurement	PKD2L1 OPCML	1.38e-03	14	117	2	EFO_0010358
Disease	Impaired cognition	CACNA1C SORL1	1.38e-03	14	117	2	C0338656
Disease	coffee consumption, cups of coffee per day measurement	EFCAB5 OPCML	1.80e-03	16	117	2	EFO_0004330, EFO_0006782
Disease	Tactile Amnesia	GNAI1 GNAI3	2.04e-03	17	117	2	C0750906
Disease	Amnestic State	GNAI1 GNAI3	2.04e-03	17	117	2	C0750907
Disease	Dissociative Amnesia	GNAI1 GNAI3	2.04e-03	17	117	2	C0236795
Disease	Hysterical amnesia	GNAI1 GNAI3	2.04e-03	17	117	2	C0233750
Disease	Temporary Amnesia	GNAI1 GNAI3	2.04e-03	17	117	2	C0233796
Disease	Amnesia	GNAI1 GNAI3	2.04e-03	17	117	2	C0002622
Disease	Global Amnesia	GNAI1 GNAI3	2.04e-03	17	117	2	C0262497
Disease	facial asymmetry measurement	CNBD1 POLE2	2.55e-03	19	117	2	EFO_0009751
Disease	resting heart rate	CACNA1C CANX C19orf47 SUN2	2.98e-03	149	117	4	EFO_0004351
Disease	progression free survival, ovarian serous carcinoma	MGAM ABCA13	3.42e-03	22	117	2	EFO_0004920, EFO_1001516
Disease	serum gamma-glutamyl transferase measurement	MYO9A NUP210L ATP8B1 FCHO1 TENM4 GSTT4 AKAP13 GNAI2 ABCC2 STKLD1	3.50e-03	914	117	10	EFO_0004532

Protein segments in the cluster

Peptide	Gene	Start	Entry
TQAFWKAVTAEFLAM	AQP4	31	P55087
LKNDYETLSLSAFWM	FAM200B	571	P0CF97
FSDAKMNLSSLAWEQ	CEACAM18	276	A8MTB9
VTMATSEWIQFFKEA	C19orf47	41	Q8N9M1
LSAFQDMWITAAEFK	ACTRT3	346	Q9BYD9
LSSFKQMWVTAADFK	ACTRT2	351	Q8TDY3
RASWLKQQFLNMTTF	SSX2IP	471	Q9Y2D8
QAKAMAEILRFFNWT	GRM2	191	Q14416
DENMSNTWKFLSHST	AKAP13	1916	Q12802
EIWETISQLFKFDMN	ABCA13	1156	Q86UQ4
MAQAFEDWNKTELDS	PGD	216	P52209
ENKDAMFVFLSDVWL	POLE2	281	P56282
AQFVDSTSWRFMEKL	ADCY10	646	Q96PN6
SEWENSFTLKMFLFQ	ANO4	586	Q32M45
IDALMAAFAFEWTKT	CAMSAP3	141	Q9P1Y5
QDFTSCFIETFKQWM	DISP1	846	Q96F81
FFWSLCTADMSLLEQ	CFLAR	401	O15519
TWFTFIQLSMDQKSD	COX7A2P2	91	O60397
ILANFKAMDSDWFAE	HADHB	386	P55084
FTEWNKKFMAASVAS	ATP8B1	666	O43520
EMASQDFFQRWKQLS	AP2A2	831	O94973
SEWENSFALKMFLFQ	ANO3	631	Q9BYT9
TLEDASFWEQKMDFS	RFWD3	611	Q6PCD5
SMKLFDSICNNKWFT	GNAI1	246	P63096
FEWFVSLLTKLEMDQ	NOX5	646	Q96PH1
MDWENCSSLTDFFLL	OR5W2	1	Q8NH69
AMINFWSENKSISFA	OR9K2	106	Q8NGE7
ETKDFWLNMAALTEA	FCHO1	706	O14526
MFIAALFTIAKTWNQ	nan	1196	O00370
FLVAFDKFWNMALTD	LSM11	186	P83369
STSFKMFLDNWNIQT	MBOAT2	331	Q6ZWT7
SMKLFDSICNNKWFT	GNAI3	246	P08754
AFSTFEWMKVKRNAS	HOXD1	201	Q9GZZ0
FQQMSRDFQAWLDTK	DST	4851	Q03001
IWDSQLLGFTFNDMF	MGAM	2001	O43451
WMQFTAAVEFIKTID	GAPVD1	1461	Q14C86
SELFFNLSMSLWGKN	FSIP2	3981	Q5CZC0
FCSWFFNSITMKDED	TMEM63C	106	Q9P1W3
ESVAEKMLTNWFAFL	PLXNA2	1431	O75051
ESVAEKMLTNWFTFL	PLXNA4	1431	Q9HCM2
MAWENQTFNSDFILL	OR2M2	1	Q96R28
MAWENQTFNSDFILL	OR2M5	1	A3KFT3
MAWENQTFNSDFLLL	OR2M7	1	Q8NG81
LNMANSIKFSVWVSF	KIF20B	261	Q96Q89
DLKLQMNFEWSDGSL	MRC2	446	Q9UBG0
KLFDDWMASNGTQSL	LNPEP	841	Q9UIQ6
MLEKFCNSTFWNSSF	ABCC2	1	Q92887
LSWMEQKEASTFNFF	PLEKHM3	106	Q6ZWE6
ISSNNWFFIEFSMLG	MGAT4D	276	A6NG13
ALMNEIQAAKNSWFS	RABGAP1L	211	B7ZAP0
MAEFQWFKEETRLAT	OPCML	251	Q14982
LAKEWFNTDSMTLNN	EFCAB5	156	A4FU69
DFLLADLAWNTMESQ	ATMIN	791	O43313
LEKMDWATFQLEITF	CD101	486	Q93033
AAAKNEAIFMWSTDL	HEATR5A	196	Q86XA9
QLADWDFSTLDSMVK	GSTT4	216	A0A1W2PR19
WENSKFDFDNVLAAM	CACNA1C	1111	Q13936
AKSDSFLDDIFAAWM	DNASE2B	241	Q8WZ79
MSAFEDTDQRNSKWA	C4orf45	141	Q96LM5
AQTWFDSRLKFNSTM	GABRG1	116	Q8N1C3
KISFNFSEIMASTGW	C9orf43	421	Q8TAL5
AAFNDSWSSFLMDVL	INPP5K	66	Q9BT40
SFWLATVDVSDMFSK	COL4A5	1646	P29400
SQFEWNSMALSTKDA	FASTKD1	816	Q53R41
SWAEFLKFRKSFQMS	GDF5-AS1	111	Q5U4N7
LWSMTSDIFFDNFII	CANX	426	P27824
KFDVWSNDVNLANLM	ADCY9	506	O60503
AEKFWALFTVDMDTA	CADPS2	876	Q86UW7
FSKIKSWEFNEVTSM	FBXO40	646	Q9UH90
AELFSQWMESSGKLN	ERAP2	771	Q6P179
LEDNTFMTLWDFLES	CCDC168	16	Q8NDH2
EFTVQMQAAWDKFLT	HBM	116	Q6B0K9
DLVFSFSTSMNEFWN	CAPN6	146	Q9Y6Q1
FSTSMNEFWNALLEK	CAPN6	151	Q9Y6Q1
LFQEATAFENMTKDW	KRBA2	36	Q6ZNG9
DNFSSLMLEWKSSNE	NUP210L	811	Q5VU65
AVFKDWLQEQMSASS	PRSS56	326	P0CW18
MFTSQQWKHLSNDFL	PARP6	136	Q2NL67
SEFFRKELLWSTEMA	RTL5	281	Q5HYW3
DFCEKNNLNFLMSSW	UTY	1126	O14607
KMWASQRAASNFTEI	SORL1	1696	Q92673
ASNILWIMFAASQAF	VCAM1	11	P19320
WIMFAASQAFKIETT	VCAM1	16	P19320
KENSSLLDSIFWMAA	MRPL32	66	Q9BYC8
FNSWEALFTKMSKTN	SMARCAD1	421	Q9H4L7
NLLKWAANSFERAMF	LCMT1	211	Q9UIC8
NFAKSLEGWLTNAMS	RFX2	476	P48378
ESMKLFDSICNNKWF	GNAI2	246	P04899
TNWLMAFLVTKEFSS	SLC2A8	416	Q9NY64
ESAWFKTFILMAAIN	SLC17A1	426	Q14916
FQNLLWSRKTFVDNM	ST8SIA1	196	Q92185
MTDTSVLDQWKASFF	SHOC1	1	Q5VXU9
NLSSRCSWQDLKDFM	SRSF6	116	Q13247
RFLNSTAISQFWAMD	BRINP2	351	Q9C0B6
SSFKQMWVTSADFKE	ACTRT1	351	Q8TDG2
AWDVKMLLEQFSFDI	ADAM17	311	P78536
DSLKSKSIFWNLMFF	ALG10	386	Q5BKT4
SLMINDSFCSIEKWQ	CLHC1	526	Q8NHS4
IWSEEFKNSTLAEMY	CNBD1	236	Q8NA66
KIKDWVSFMSSFRQD	PLEKHS1	116	Q5SXH7
DSASNLLFKWRNMAD	CTPS2	276	Q9NRF8
MSWFNASQLSSFAKQ	TMF1	1	P82094
AAEFSSNWQKEAMRL	SUN2	291	Q9UH99
YLFQAKDEAEMSSWL	SPTBN2	2306	O15020
WMAPEALNFSFSQKS	STKLD1	201	Q8NE28
NAKATILWDNAFSEM	STAT6	421	P42226
RMQDFWSLLTFSSDL	STAG3L4	11	Q8TBR4
TVSWMASENAFDSFL	TNC	1546	P24821
SQDIKCFMTDVNSWL	TENM4	2461	Q6N022
QTFLLFDSEKRMWTT	RAET1L	146	Q5VY80
EAQSAWKDDFALNSM	YJU2B	171	P13994
EKTNFKTLSSMEDFW	PKD2	266	Q13563
SSKLWMLEFSAFLEQ	TEAD4	221	Q15561
NKEMSKEWFLFNDSR	USP38	906	Q8NB14
VSFQAISSMADFWDF	PKD2L1	146	Q9P0L9
NMQNIKSSLEAASFW	RIOK2	536	Q9BVS4
WLFLDSSTSMFINAR	ERCC4	326	Q92889
WCSMIELNFKDAFDS	TTC39C	361	Q8N584
QFFDTWAMNDDTVLK	USP6	326	P35125
EHFSESQDMTNWKLT	ZFYVE9	391	O95405
FDDFAAALVTLWNLM	TPCN2	636	Q8NHX9
LAIEGLWSMNFTFNK	NLRP13	486	Q86W25
LWSMNFTFNKEDTEI	NLRP13	491	Q86W25
NSMAKSLYSALFDWI	MYO9A	496	B2RTY4